
Gaudium IVF and Women Health Ltd, a fertility services provider, raised Rs 165 crore through an IPO priced between Rs 75-79 per share, which was oversubscribed 7.27 times overall, led by strong demand from retail and non-institutional investors. The shares debuted on February 27, 2026, listing at Rs 83 on NSE and BSE, a 5% premium over the issue price, surpassing grey market expectations. The company plans to use proceeds for expanding IVF centers, loan repayment, and corporate purposes. Despite a positive listing, the stock experienced some volatility amid broader market weakness.
Select a news story to see related coverage from other media outlets.